2021 Annual review
In 2021, our guarantees accelerated access to products to tackle HIV, TB, malaria, syphilis and COVID-19. We also launched our 2021-2025 strategy, which will see us expand our work further.
Read our 2021 Annual review to find out how we used innovative finance to increase access to healthcare products.
30 June 2022